Your browser doesn't support javascript.
loading
Evaluation and Treatment of Febrile Ulceronecrotic Mucha-Habermann Disease With Ruxolitinib and Tocilizumab as Guided by Cytokine Profile.
Wu, Richard; DiLorenzo, Ashley; Lotke, Michael; Habeshian, Kaiane; Brooks, Joel; Keller, Michael D; Kirkorian, A Yasmine.
Afiliación
  • Wu R; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
  • DiLorenzo A; Department of Dermatology, MedStar Washington Hospital Center, Washington, DC.
  • Lotke M; Division of Hospitalist Medicine, Children's National Hospital, Washington, DC.
  • Habeshian K; Division of Dermatology, Children's National Hospital, Washington, DC.
  • Brooks J; George Washington University School of Medicine & Health Sciences, Washington, DC.
  • Keller MD; George Washington University School of Medicine & Health Sciences, Washington, DC.
  • Kirkorian AY; Division of Allergy and Immunology, Children's National Hospital, Washington, DC.
JAMA Dermatol ; 157(11): 1381-1383, 2021 11 01.
Article en En | MEDLINE | ID: mdl-34643656

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pitiriasis Liquenoide Límite: Humans Idioma: En Revista: JAMA Dermatol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pitiriasis Liquenoide Límite: Humans Idioma: En Revista: JAMA Dermatol Año: 2021 Tipo del documento: Article